![]() |
|
|
Vol. 295, Issue 2, 484-491, November 2000
Vascular Biology Laboratory, Dalton Cardiovascular Research Center,
and Department of Physiology, School of Medicine, University of
Missouri, Columbia, Missouri (B.J.F.H., B.R.W., M.S.); and Department
of Physiology, School of Medicine, East Carolina University,
Greenville, North Carolina (L.C.K.)
Arterial injury models for coronary artery disease have demonstrated an
enhanced expression and function of either the endothelinA or endothelinB (ETA or ETB)
receptor subtype. We hypothesized that organ culture would enhance the
physiological function of ET receptors in the porcine right coronary
artery. Arteries were either cold stored (4°C) or organ cultured
(37°C) for 4 days. After 4 days, the artery was either 1) sectioned
into rings to measure the ET-1-induced isometric tension response
(3 × 10
10-3 × 10
7 M), or 2)
enzymatically dispersed and the isolated smooth muscle cells imaged
using fura-2 to measure the myoplasmic calcium (Cam) response to 3 × 10
8 M ET-1 (~EC50).
Isometric tension and Cam to ET-1 were measured in the
absence and presence of bosentan (nonselective ETA or
ETB receptor antagonist), BQ788 (ETB-selective
antagonist), and BQ123 (ETA-selective antagonist). Compared
with cold storage, organ culture induced a 2-fold increase in tension
development (3 × 10
7 M ET-1) and Cam
(3 × 10
8 M ET-1), which was inhibited with
bosentan, thus confirming the enhanced responses to ET-1 were due to ET
receptor activation. BQ123 also inhibited the enhanced contraction and
Cam responses to ET-1. In contrast, BQ788 failed to inhibit
tension development and Cam responses to ET-1 in organ
culture and cold storage. Sarafotoxin 6C (ETB agonist)
failed to elicit an increased Cam response in organ culture
compared with cold storage. Our results indicate the increased tension
development and Cam responses to ET-1 in organ culture are
attributable to ETA receptors, and not ETB receptors.
This article has been cited by other articles:
![]() |
S. A. Kempson, J. M. Edwards, A. Osborn, and M. Sturek Acute inhibition of the betaine transporter by ATP and adenosine in renal MDCK cells Am J Physiol Renal Physiol, July 1, 2008; 295(1): F108 - F117. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Witczak, B. R. Wamhoff, and M. Sturek Exercise training prevents Ca2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic yucatan swine J Appl Physiol, September 1, 2006; 101(3): 752 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kempson, J. M. Edwards, and M. Sturek Inhibition of the renal betaine transporter by calcium ions Am J Physiol Renal Physiol, August 1, 2006; 291(2): F305 - F313. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Maddali, D. H. Korzick, D. L. Tharp, and D. K. Bowles PKC{delta} Mediates Testosterone-induced Increases in Coronary Smooth Muscle Cav1.2 J. Biol. Chem., December 30, 2005; 280(52): 43024 - 43029. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shen, C. I. Seye, M. Wang, G. A. Weisman, P. A. Wilden, and M. Sturek Cloning, Up-Regulation, and Mitogenic Role of Porcine P2Y2 Receptor in Coronary Artery Smooth Muscle Cells Mol. Pharmacol., November 1, 2004; 66(5): 1265 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lee, B. R. Wamhoff, L. C. Katwa, H. K. Reddy, D. J. Voelker, J. L. Dixon, and M. Sturek Increased Endothelin-Induced Ca2+ Signaling, Tyrosine Phosphorylation, and Coronary Artery Disease in Diabetic Dyslipidemic Swine Are Prevented by Atorvastatin J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 132 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Wamhoff, D. K. Bowles, N. J. Dietz, Q. Hu, and M. Sturek Exercise training attenuates coronary smooth muscle phenotypic modulation and nuclear Ca2+ signaling Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2397 - H2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Ojuka, T. E. Jones, D.-H. Han, M. Chen, B. R. Wamhoff, M. Sturek, and J. O. Holloszy Intermittent increases in cytosolic Ca2+ stimulate mitochondrial biogenesis in muscle cells Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1040 - E1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Ojuka, T. E. Jones, L. A. Nolte, M. Chen, B. R. Wamhoff, M. Sturek, and J. O. Holloszy Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca2+ Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1008 - E1013. [Abstract] [Full Text] [PDF] |
||||